Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Immunofluorescence
100%
Neuromyelitis Optica Spectrum Disorder (NMOSD)
100%
Co-immunoprecipitation (co-IP)
100%
Immunoprecipitation Assay
100%
Immunohistochemical Assay
100%
Neuromyelitis Optica
57%
Mayo Clinic
42%
Combined Assay
42%
Minnesota
28%
Rochester
28%
Neuromyelitis optica-IgG
28%
Sensitivity Rate
28%
Longitudinally Extensive Transverse Myelitis
28%
Clinical Practice
14%
Neurology Department
14%
Arizona
14%
Florida
14%
Clinical Information
14%
Jacksonville
14%
Green Fluorescent Protein
14%
Aquaporin-4 (AQP4)
14%
Neuroimmunology
14%
Immunofluorescence Assay
14%
Optic Neuritis
14%
Monophasic
14%
Design Case
14%
Combined Test
14%
Practice-based Studies
14%
Sensitivity Increase
14%
Scottsdale
14%
Disorder Diagnosis
14%
Serological Studies
14%
Measurement Sensitivity
14%
Medicine and Dentistry
Sensitivity and Specificity
100%
Immunoprecipitation
100%
Spectrum Disorder
100%
Neuromyelitis Optica
100%
Immunofluorescence
72%
Transverse Myelitis
18%
Neurology
9%
Green Fluorescent Protein
9%
Aquaporin 4
9%
Optic Neuritis
9%
Case-Control Study
9%
Neuroscience
Neuromyelitis Optica
100%
Immunoprecipitation
100%
Spectrum Disorder
100%
Immunofluorescence
72%
Myelitis
18%
Transverse Myelitis
18%
Aquaporin 4
9%
Green Fluorescent Protein
9%
Optic Neuritis
9%
Neuroimmunology
9%
Nursing and Health Professions
Sensitivity and Specificity
100%
Myelooptic Neuropathy
100%
Immunoprecipitation
100%
Immunofluorescence
72%
Myelitis
18%
Clinical Practice
9%
Case-Control Study
9%
Aquaporin 4
9%
Optic Neuritis
9%
Green Fluorescent Protein
9%